Wynn Resorts Leads Notable Misses in a Broad Q3 2026 Earnings Wave

A wide swath of companies reported third-quarter 2026 results on November 5, spanning energy, biotech, gaming, and consumer sectors. The most prominent disappointment came from Wynn Resorts, which missed Wall Street's earnings estimate by $0.39 per share and fell short on revenue, sending the stock lower.

In energy, Permian Resources stood out with an upbeat update, reporting Q3 results and raising its full-year 2026 oil production guidance midpoint to 202,000 barrels per day while projecting Q4 output above 210,000 barrels per day. Baytex Energy also made forward-looking moves, announcing an increased 2026 capital plan alongside 2027 guidance and an accelerated three-year growth outlook.

In healthcare, Akebia Therapeutics posted a sharp revenue decline, with total revenues falling to $36.9 million in Q3 2026 from $58.8 million a year earlier, driven primarily by lower Auryxia net product revenues of $20.0 million. Tenax Therapeutics reported a net loss of $16.7 million for the quarter but held $113.7 million in cash and equivalents as of September 30. Adicet Bio highlighted continued clinical progress for its lead therapy prula-cel across autoimmune and oncology indications.